Healthcare

Drugmakers Ink $242M Settlement In Ill. Medicaid Fraud Case

A group of major pharmaceutical companies has agreed to pay a combined $242 million to resolve allegations they bilked Illinois’ government by inflating prices for medicines covered by the state’s Medicaid program, the Prairie State’s attorney general announced Monday…

Read this piece in its entirety at Law360.

Reckitt Spared Fees In ‘Close Call’ After Losing Mucinex Suit

Reckitt Benckiser LLC won’t have to pay attorney fees racked up by generic-drug makers it unsuccessfully sued on claims that they ripped off patents for its Mucinex respiratory relief drug, although a New Jersey federal judge on Friday said the decision on the fees was a “close call”…

Read this piece in its entirety at Law360.

Actavis Asks Full Fed. Circ. To Nix ‘Amorphous’ Panel Ruling

Actavis Laboratories FL Inc. asked the full Federal Circuit on Wednesday to revisit an August panel decision in a case over weight loss pill patents, citing a partial dissent by one of the panel judges who had argued the decision wrongly created a “new rule” for written description…

Read this piece in its entirety at Law360.

Texas Judge Tosses ACA’s Transgender, Abortion Bias Rule

The Texas federal judge who vacated the Affordable Care Act last year tossed an Obama-era regulation banning federally funded health insurance plans from discriminating on the basis of gender identity, saying the rule violated the Administrative Procedure Act and the Religious Freedom Restoration Act…

Read this piece in its entirety at Law360.